China AI Snubs Takaichi Condolences Diplomatic Tensions Could Weigh on JapanChina Trade Page Industries Reports Volume Rebound After Three Years Margins Under Pressure SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaways Market Value on Debut Traders Predict World Insurance Expands Midwest Footprint with Kansas Agency Acquisition Stellantis Turnaround Strategy Prediction Market Oversight and Oura IPO Filing Highlight Key Market Developments Goldman Sachs Russian Crude Exports Remain Stable Despite Latest US Sanctions FMX Q1 2026 Earnings Profit Falls Sharply Short of Street Estimates STKS Q1 2026 Earnings EPS Misses Estimates as Company Faces Operating Headwinds THCH Q4 2025 Earnings Deep Loss Reported Amidst Limited Disclosure ATLCP Q1 2026 Earnings Earnings Per Share Surpasses Estimates by Nearly 26 Astrotech Corporation ASTC Q1 2024 Earnings Net Loss Deepens as Company Focuses on Technology Commercialization TFX Q1 2026 Earnings EPS Surges Past Estimates Despite Market Headwinds Unifi Inc UFI Edges Higher as Stock Tests Key Resistance Level Processa Pharmaceuticals PCSA Surges 575 as Shares Test Key Resistance Level LKQ Corporation Gains 1 as Stock Approaches Key Resistance at 2851 AI Infrastructure Acquisition Corp AIIA Holds Steady at 1012 as Trading Action Remains Subdued Victory Capital Holdings VCTR Edges Higher as Shares Test Key Resistance Zone UK Chancellor Reeves Announces VAT Cut for Theme Parks and Childrens Meals to Ease CostofLiving Pressures BRC Group Holdings Inc RILY Q1 2024 Earnings Loss Per Share of 171 Stock Rises 424 Amid Sparse Data FRP Holdings Inc FRPH Gains 256 as Stock Approaches Key Resistance Level Aemetis AMTX Posts Modest Gain as Renewable Energy Stock Tests Resistance MARA Holdings MARA Declines 21 as Bitcoin Volatility Weighs on Mining Stocks Corebridge Financial Junior Subordinated Notes CRBD Edge Lower by 004 as Yields Hold Steady Portillos Inc PTLO Holds Near Support After Marginal Decline Wintergreen Acquisition Corp WTG Holds Steady Near Trust Value Amid Low Volume Revelation Biosciences REVB Extends Gains as Shares Approach Resistance at 114 Jazz Pharmaceuticals JAZZ Shares Dip 132 as Stock Tests Key Support Levels